Health X Platform Ltd
Health X Platform Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months. RetailerShakti is expected to be EBITDA positive by Q4 FY26 and achieve around 1% EBITDA margin in FY26.
From Health X Platform Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months.
- RetailerShakti is expected to grow rapidly at over 30% CAGR over the next 2-3 years, targeting INR 4,000 crore revenue by 2030.
- Overall company revenue target for FY '29-'30 is INR ~6,000 crore (INR 4,000 crore from RetailerShakti and INR 2,000 crore from B2C).
- HealthBuddy network to expand from current 260 to about 360 within 18 months, targeting INR 1 crore sales per HealthBuddy annually.
- Working capital efficiency will improve, aiming to reduce working capital to 3%-4% of revenue in 3-5 years, improving liquidity and scalability.
2 more points from Health X Platform Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Health X Platform Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current/future capex primarily focused on technology, AI development, warehouse automation, and satellite warehouse expansion.
- Planned capex amount around INR 40-50 crores annually, funded comfortably through internal accruals and treasury income (INR 400+ crores available).
- No plans to raise external capital for at least next 5 years.
- Automation at fulfillment centers aims to double fulfillment capacity and reduce costs.
- Building new warehouses strategically (e.g., Udaipur) to expand geographical reach gradually without hurried capital deployment.
2 more points from Health X Platform Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Health X Platform Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Health X Platform Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Health X Platform Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹346 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Health X Platform Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Arthneeti Pro · Annual
Health X Platform Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Health X Platform Ltd Q2 FY26 results?
Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months. RetailerShakti is expected to be EBITDA positive by Q4 FY26 and achieve around 1% EBITDA margin in FY26.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.
Is Health X Platform Ltd planning capital expenditure?
Current/future capex primarily focused on technology, AI development, warehouse automation, and satellite warehouse expansion.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.